Evidence map›Paper›PMID 30143865›Full record

ArticlePharmaceutical research2018

In Silico Prediction of Major Clearance Pathways of Drugs among 9 Routes with Two-Step Support Vector Machines.

Naomi Wakayama, Kota Toshimoto, Kazuya Maeda, Shun Hotta, Takashi Ishida, Yutaka Akiyama, Yuichi Sugiyama

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Predicting the Drug Clearance Pathway with Structural Descriptors.European journal of drug metabolism and pharmacokinetics · 2022
    Article
  5. Two experts and a newbie: [European journal of nuclear medicine and molecular imaging · 2022
    Article
  6. Review
  7. Article
  8. Kinetic Modeling of Steady-State Situations in Cytochrome P450 Enzyme Reactions.Drug metabolism and disposition: the biological fate of chemicals · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Naomi WakayamaDrug Metabolism and Pharmacokinetics Japan, Biopharmaceutical Assessment Core Function Unit, Medicine Development Center, Eisai Co., Ltd., Tokyo, Japan.
Kota ToshimotoDepartment of Computer Science, Graduate School of Information Science and Engineering, Tokyo Institute of Technology, Tokyo, Japan.
Kazuya MaedaLaboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan.
Shun HottaDepartment of Computer Science, Graduate School of Information Science and Engineering, Tokyo Institute of Technology, Tokyo, Japan.
Takashi IshidaDepartment of Computer Science, Graduate School of Information Science and Engineering, Tokyo Institute of Technology, Tokyo, Japan.
Yutaka AkiyamaDepartment of Computer Science, Graduate School of Information Science and Engineering, Tokyo Institute of Technology, Tokyo, Japan.
Yuichi SugiyamaSugiyama Laboratory, RIKEN Baton Zone Program, RIKEN Cluster for Science, Technology and Innovation Hub, RIKEN, Yokohama, Japan. ychi.sugiyama@riken.jp.ORCID http://orcid.org/0000-0002-8452-8835

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe clearance pathways of drugs are critical elements for understanding the pharmacokinetics of drugs. We previously developed in silico systems to predict the five clearance pathway using a rectangular method and a support vector machine (SVM). In this study, we improved our classification system by increasing the number of clearance pathways available for our prediction (CYP1A2, CYP2C8, CYP2C19, and UDP-glucuronosyl transferases (UGTs)) and by accepting multiple major pathways.

methodsUsing the four default descriptors (charge, molecular weight, logD at pH 7.0, and unbound fraction in plasma), three kinds of SVM-based predictors based on traditional single-step approach or two-step focusing approaches with subset or partition clustering were developed. The two-step approach with subset clustering resulted in the highest prediction performance. The feature-selection of additional descriptors based on a greedy algorithm was employed to further improve the predictability.

resultsThe prediction accuracy for each pathway was increased to more than 0.83 with the exception of CYP2C19 and UGTs pathways, whose accuracies were below 0.7. Prediction performance of CYP1A2, CYP3A4 and renal excretion pathways were found to be acceptable using external dataset.

conclusionsWe successfully constructed a novel SVM-based predictor for the multiple major clearance pathways based on chemical structures.

Indexed as

Computer SimulationSupport Vector MachineAlgorithmsCytochrome P-450 Enzyme SystemDatabases, PharmaceuticalGlucuronosyltransferaseHumansPharmaceutical PreparationsPharmacokineticsCytochrome P-450 Enzyme SystemGlucuronosyltransferasePharmaceutical Preparationsclearance pathwaycytochrome P450in silico predictionsupport vector machineUDP-glucuronosyltransferase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.